{
  "meta": {
    "title": "Adrenal_Gland",
    "url": "https://brainandscalpel.vercel.app/adrenal-gland-523f33fb.html",
    "scrapedAt": "2025-11-30T11:19:54.137Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Cortisol</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Corticosterone</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldosterone</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hormones is synthesized by all the three layers of adrenal cortex?</span></p>",
      "unique_key": "DT1320802",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320802,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Corticosterone is the only hormone that is produced in measurable amounts by all three zones of the adrenal cortex.</p>\n<ul>\n<li>The adrenal cortex consists of three layers:\n<ul>\n<li><strong>Zona glomerulosa (outermost): synthesises mineralocorticoids (mainly aldosterone)</strong></li>\n<li><strong>Zona fasciculata (middle): synthesises glucocorticoids (mainly cortisol and some corticosterone)</strong></li>\n<li><strong>Zona reticularis (innermost): synthesises androgens (mainly DHEA and androstenedione)</strong></li>\n</ul>\n</li>\n<li>Corticosterone is synthesised in all three zones, although it is not the dominant hormone in any. <strong>(Other options ruled out)</strong></li>\n<li>It serves as:\n<ul>\n<li>A precursor for aldosterone in the zona glomerulosa.</li>\n<li>A minor glucocorticoid in the zona fasciculata.</li>\n<li>Produced to a lesser extent in the zona reticularis.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082270073d54-7ca4-40ad-84b5-e96e1980dca5.png\">\n<p><strong>Key Takeaways:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202503182abac108-9a42-4305-a441-7abd67894f0c.jpg\">",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoid activity</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Mineralocorticoid activity</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Both a & b</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old man with metastatic brain oedema was started on a synthetic corticosteroid to reduce cerebral inflammation. Over time, his serum sodium remained normal, and potassium levels showed no significant change. Which of the following best describes the pharmacological activity of the drug he is likely receiving?</span></p>",
      "unique_key": "DT1320858",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320858,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Normal sodium and potassium levels in this patient, despite corticosteroid therapy, point toward a drug lacking mineralocorticoid activity. Dexamethasone, a synthetic glucocorticoid, fits this profile as it exerts potent anti-inflammatory action with minimal or no mineralocorticoid effects.</p>\n<ul>\n<li>Dexamethasone is widely used to manage cerebral oedema due to its ability to reduce vascular permeability and intracranial pressure without causing fluid and electrolyte imbalances.</li>\n<li>Unlike mineralocorticoids (e.g., aldosterone), dexamethasone does not act significantly on the renal tubules and thus does not disturb sodium or potassium homeostasis. <strong>(Option B ruled out)</strong></li>\n<li>This property is clinically beneficial in patients with cerebral oedema or intracranial malignancies, where fluid retention would be detrimental.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250822618a3492-106f-4c6f-bcf6-567cd2e63c57.png\">",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Angiotensin II</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Cortisol releasing hormone</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Progesterone</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hormones enhances conversion of cholesterol to pregnenolone?</span></p>",
      "unique_key": "DT1320859",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320859,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Conversion of cholesterol to pregnenolone is the first step in the synthesis of Steroid hormones.</li>\n<li><strong>Angiotensin II </strong>binds to AT1 receptors in the zona glomerulosa that act via a G-protein to activate phospholipase C. The resulting increase in protein kinase C fosters the conversion of cholesterol to pregnenolone.</li>\n<li><strong>Cortisol</strong><strong>releasing hormone</strong> increases the secretion of ACTH from the anterior pituitary gland. CRH does not have any direct effect on above mentioned conversion. ACTH via Gs adenylyl cyclase increases the formation of pregnenolone. <strong>(Option B ruled out)</strong></li>\n<li><strong>Progesterone</strong>, via a negative feedback loop, acts on the hypothalamus to alter FSH and LH that inhibit pregnenolone formation.<strong> (Option C ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholesterol desmolase deficiency</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Steroidogenic acute regulatory protein</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">21-beta hydroxylase deficiency</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A newborn child was presented to the doctor. Pediatrician evaluated the baby. He found that the patient has a mutation in the gene causing congenital adrenal hyperplasia in the newborn. The probable cause is</span></p>",
      "unique_key": "DT1320860",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320860,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>StAR protein mutation causes congenital lipoid adrenal hyperplasia by impairing cholesterol transport into mitochondria, blocking all adrenal steroidogenesis despite intact enzymatic machinery.</p>\n<ul>\n<li>The StAR protein facilitates the transfer of cholesterol from the outer to the inner mitochondrial membrane, an essential step in steroid hormone synthesis.</li>\n<li>Without StAR, cholesterol cannot reach cholesterol desmolase (side-chain cleavage enzyme), halting the synthesis of all steroid hormones (glucocorticoids, mineralocorticoids, and sex steroids).</li>\n<li>This results in adrenal insufficiency and hyperplasia due to unopposed ACTH stimulation.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Option A (Cholesterol desmolase deficiency):</strong> This deficiency is fatal in utero because it prevents the placenta from making the progesterone necessary for pregnancy to continue. The fetus dies in utero.</p>\n<p><strong>Option C (21-beta hydroxylase deficiency):</strong> It causes a decrease in the formation of cortisol and aldosterone. The pathway diverts towards androgens, producing virilization. In females, it is known as adrenogenital syndrome. It is usually diagnosed in later stages of life.</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Pregnancy</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrosis</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cortisol binding globulin level is elevated in</span></p>",
      "unique_key": "DT1320861",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320861,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Estrogen stimulates hepatic synthesis of cortisol-binding globulin (CBG) during pregnancy, leading to elevated total plasma cortisol while maintaining normal free cortisol levels.</p>\n<ul>\n<li>Cortisol in plasma is mostly bound to cortisol-binding globulin (CBG), also known as transcortin, and to a lesser extent to albumin.</li>\n<li>Only free (unbound) cortisol is biologically active.</li>\n<li>In pregnancy, estrogen increases CBG production by the liver, raising total cortisol levels.</li>\n<li>The transient fall in free cortisol triggers increased ACTH secretion, stimulating more cortisol release to re-establish equilibrium with normal free cortisol levels.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Cirrhosis (Option A):</strong> Decreased hepatic protein synthesis &rarr; decreased CBG &rarr; reduced total cortisol.</p>\n<p><strong>Nephrotic syndrome (Option C):</strong> Loss of proteins in urine reduces plasma CBG.</p>\n<p><strong>Multiple myeloma (Option D):</strong> Displacement of binding proteins by abnormal immunoglobulins leads to lower CBG.</p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Na&#8314; loss and shock due to hypovolemia</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in blood glucose</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperlipidemia</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased protein catabolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old female visited the primary care center. She was sent to the endocrinologist. The endocrinologist evaluated the patient and diagnosed her with adrenal insufficiency. Which among the following is a feature of adrenal insufficiency?</span></p>",
      "unique_key": "DT1320863",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320863,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Loss of aldosterone in adrenal insufficiency leads to urinary sodium loss, dehydration, and hypovolemic shock.</p>\n<ul>\n<li>Primary adrenal insufficiency (Addison's disease) results in a deficiency of both glucocorticoids and mineralocorticoids.</li>\n<li>Aldosterone deficiency &rarr; increased Na&#8314; and water loss, leading to hypovolemia, hypotension, and shock.</li>\n<li>Cortisol deficiency &rarr; decreased gluconeogenesis, hypoglycemia, and decreased protein/lipid metabolism. <strong>(other options ruled out)</strong></li>\n<li>Features of glucocorticoid deficiency include fatigue, weight loss, and poor stress tolerance.</li>\n<li>Hyperpigmentation may also occur due to increased ACTH secretion in primary adrenal insufficiency.</li>\n</ul>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Red blood cells</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphocytes</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Neutrophils</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Monocytes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cortisol treated person has a decrease in which of the following cell counts?</span></p>",
      "unique_key": "DT1320864",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320864,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Glucocorticoids like cortisol decrease the number of circulating lymphocytes by inhibiting their mitotic activity and promoting apoptosis.</p>\n<ul>\n<li><strong>The effect of cortisol administration on blood cells is as follows.</strong>\n<ul>\n<li>Red blood cell count - Increase <strong>(Option A ruled out)</strong></li>\n<li>Platelet count - Increase</li>\n<li>Neutrophil count - Increase <strong>(Option C ruled out)</strong></li>\n<li>Monocyte count - Increase <strong>(Option D ruled out)</strong></li>\n<li>Eosinophil count - Decrease</li>\n<li>Basophil count - Decrease</li>\n<li>Lymphocyte count - Decrease</li>\n</ul>\n</li>\n<li>The reduced secretion of the cytokine IL-2 leads to reduced proliferation of lymphocytes and causes apoptosis.</li>\n<li>Inhibition of NF-&kappa;B activity &rarr; decreases cytokine production.</li>\n<li>Lymphoid organ shrinkage &rarr; decreases the lymphocyte count in blood.</li>\n</ul>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing disease</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing syndrome</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothalamic disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male has Purple striae on the abdomen and moon face. He visited the doctor for management. He found that the patient has an ACTH-dependent tumor of the anterior pituitary gland. The probable diagnosis in this patient is</span></p>",
      "unique_key": "DT1320865",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320865,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<p>Cushing disease refers specifically to ACTH-dependent hypercortisolism caused by a pituitary adenoma. This leads to overproduction of cortisol, causing classical signs such as moon facies, purple striae, and truncal obesity.</p>\n<ul>\n<li>Common causes are anterior pituitary tumor, ACTH ACTH-secreting lung tumor or any other ACTH-secreting tumor.</li>\n<li><strong>Addison's disease</strong>is caused by deficiency of cortisol in an individual. This person has reduced resistance to stress. (<strong>Option B ruled out)</strong></li>\n<li>ACTH-independent increase secretion of cortisol produces <strong>Cushing's syndrome.</strong>Probable causes include glucocorticoid-secreting adrenal tumors, adrenal hyperplasia, and prolonged administration of exogenous glucocorticoids for diseases such as rheumatoid arthritis. <strong>(Option C ruled out)</strong></li>\n<li><strong>Hypothalamic disorder</strong> causes an increase or decrease in the level of cortisol-releasing hormone.<strong> (Option D ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth inhibition</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduce histamine release from mast cells</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal insufficiency</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In large doses of exogenous glucorticoid administration, which of the following effect/ effects is seen?</span></p>",
      "unique_key": "DT1320867",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320867,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Large doses of glucocorticoids inhibit growth, decrease growth hormone secretion. <strong>(Option A)</strong></li>\n<li>Glucocorticoids inhibit the inflammatory response to tissue injury. High levels of glucocorticoids suppress manifestations of allergic disease that are due to the release of histamine from mast cells and basophils. <strong>(Option B)</strong></li>\n<li>Large doses of exogenous glucocorticoid treatment inhibit the ACTH secretion from the anterior pituitary gland. Withdrawal of cortisol produces severe adrenal insufficiency and Addisonian crisis. <strong>(Option C)</strong></li>\n</ul>\n<p>Other effects of large doses of steroids are:</p>\n<ul>\n<li>Decrease thyroid-stimulating hormone secretion</li>\n<li>Frequent infections</li>\n<li>Frank psychosis in long-term use</li>\n<li>Osteoporosis</li>\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleus tractus solitarius</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Nociceptive stimulus</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Emotional outburst</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Circadian rhythm drive</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following has an inhibitory effect on cortisol-releasing hormone?</span></p>",
      "unique_key": "DT1320868",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320868,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Cortisol releasing hormone is released from the hypothalamic paraventricular nuclei. It is secreted in the median eminence and transported to the anterior pituitary gland.</li>\n<li>Afferent nerve pathways from many parts of the brain converge on the paraventricular nuclei.\n<ul>\n<li>Amygdaloid body - Emotional stress</li>\n<li>Suprachiasmatic nuclei - circadian rhythm</li>\n<li>Nociceptive stimulus- Via the ascending spinal pathway</li>\n</ul>\n</li>\n<li>The above stimuli increase CRH secretion, which increases ACTH and finally cortisol secretion.</li>\n<li>Baroreceptors via the nucleus tractus solitarius inhibit the CRH secretion.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Nociceptive stimulus (Option B): </strong>Increases CRH via activation of ascending pain pathways.</p>\n<p><strong>Emotional outburst (Option C):</strong> Emotional stress enhances CRH secretion via amygdala-limbic-HPA connectivity.</p>\n<p><strong>Circadian rhythm drive (Option D):</strong> SCN provides circadian input to the PVN &rarr; drives the diurnal rhythm of CRH.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>CRH secretion is tightly regulated. While many stress-related stimuli enhance its release, baroreceptor inputs via the nucleus tractus solitarius provide inhibitory modulation.</p>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypernatremia</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperkalemia</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Alkalosis</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following effects is not produced by excess aldosterone?</span></p>",
      "unique_key": "DT1320869",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320869,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Excess aldosterone enhances sodium reabsorption and potassium/hydrogen excretion in the renal collecting ducts, leading to hypernatremia, hypokalemia, and metabolic alkalosis, not hyperkalemia.</p>\n<ul>\n<li>Aldosterone is secreted by the zona glomerulosa of the adrenal cortex and acts primarily on the principal cells of the renal collecting ducts.</li>\n<li>It promotes Na&#8314; reabsorption in exchange for K&#8314; and H&#8314; secretion.</li>\n<li>Excess aldosterone leads to:\n<ul>\n<li>Hypernatremia: due to increased Na&#8314; reabsorption. <strong>(Option A ruled out)</strong></li>\n<li>Hypokalemia: due to enhanced urinary K&#8314; loss.</li>\n<li>Metabolic alkalosis: from loss of H&#8314; ions in the distal nephron. <strong>(Option C ruled out)</strong></li>\n</ul>\n</li>\n<li>It also affects sodium conservation from sweat, saliva, and the colon.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Hypernatremia (Option A):</strong> Seen due to increased Na&#8314; reabsorption via ENaC channels under aldosterone action.</p>\n<p><strong>Alkalosis (Option C):</strong> Aldosterone enhances H&#8314; secretion via H-ATPase in intercalated cells, leading to metabolic alkalosis.</p>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Mineralocorticoid receptor has higher affinity to glucocorticoids</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Mineralocorticoid sensitive tissues has 11&beta;-hydroxysteroid dehydrogenase</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">11-deoxy derivatives can not bind to mineralocorticoid receptors</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True about mineralocorticoid and glucocorticoid receptors is</span></p>",
      "unique_key": "DT1320870",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320870,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Glucocorticoids such as cortisol bind with high affinity to mineralocorticoid receptors; however, in mineralocorticoid-sensitive tissues, local expression of 11&beta;-HSD2 converts active cortisol to inactive cortisone, preventing unwanted activation.</p>\n<ul>\n<li>Mineralocorticoid Receptor Affinity:\n<ul>\n<li>The mineralocorticoid receptor (MR) has a high affinity for both aldosterone and cortisol, often even higher for cortisol.</li>\n</ul>\n</li>\n<li>Enzymatic Protection via 11&beta;-HSD2:\n<ul>\n<li>Tissues like the kidney, colon, and salivary glands, which are sensitive to mineralocorticoids, express 11&beta;-hydroxysteroid dehydrogenase type 2 (11&beta;-HSD2).</li>\n<li>This enzyme converts cortisol to cortisone and corticosterone to 11-dehydrocorticosterone, both of which are inactive at MR.</li>\n</ul>\n</li>\n<li>11-Deoxy Derivatives:\n<ul>\n<li>Compounds like 11-deoxycortisol and 11-deoxycorticosterone cannot bind to the MR effectively and lack mineralocorticoid activity.</li>\n</ul>\n</li>\n<li>Clinical Correlation:\n<ul>\n<li>In Apparent Mineralocorticoid Excess (AME), due to mutation or inhibition of 11&beta;-HSD2, cortisol can activate MR, mimicking excess aldosterone.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318ce580342-dabb-4471-be9b-c9c03938af5d.jpg\">",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">High potassium intake</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Low sodium intake</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary hyperaldosteronism</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemorrhage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the condition in which mineralocorticoid and glucocorticoid secretion is increased.</span></p>",
      "unique_key": "DT1320871",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320871,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Both glucocorticoid and mineralocorticoid secretion rise in response to physiological stress like hemorrhage, via activation of the HPA axis and RAAS system.</p>\n<ul>\n<li><strong>Hemorrhage</strong> activates both the <strong>hypothalamic-pituitary-adrenal (HPA) axis</strong> and the <strong>renin-angiotensin-aldosterone system (RAAS)</strong>:\n<ul>\n<li><strong>ACTH secretion</strong> is stimulated- increased cortisol release.</li>\n<li><strong>Renin release</strong> is triggered - increases Angiotensin II - increases Aldosterone.</li>\n<li>This dual hormonal surge helps conserve volume and maintain glucose and vascular tone during shock states.</li>\n</ul>\n</li>\n<li><strong>Conditions which causes increase in the secretion of both are</strong>\n<ul>\n<li>Surgery</li>\n<li>Anxiety</li>\n<li>Trauma</li>\n<li>Stress</li>\n</ul>\n</li>\n<li><strong>Conditions which cause only increase in mineralocorticoid are</strong>\n<ul>\n<li>High K+ intake</li>\n<li>High Na+ intake</li>\n<li>Thoracic compression in the inferior vena cava</li>\n<li>Standing</li>\n<li>Secondary hyperaldosteronism</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>High potassium intake (Option A):</strong> Stimulates aldosterone release to enhance renal potassium excretion. Does not affect cortisol.</p>\n<p><strong>Low sodium intake (Option B):</strong> Triggers aldosterone via RAAS, with no change in glucocorticoids.</p>\n<p><strong>Secondary hyperaldosteronism (Option C):</strong> Driven by increased renin, leading to isolated mineralocorticoid elevation, not glucocorticoid.</p>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Monoamine oxidase</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboxy o-methyltransferase</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylethanolamine-N-methyltransferase</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following enzymes is required for the synthesis of norepinephrine from epinephrine?</span></p>",
      "unique_key": "DT1320874",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320874,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Epinephrine and norepinephrine are synthesized from the adrenal medulla gland.</li>\n<li>Phenylethanolamine-N-methyltransferase (PNMT), the enzyme catalyzes the formation of epinephrine from norepinephrine,</li>\n<li>It is found in good quantities only in the brain and the adrenal medulla.</li>\n<li>PNMT is induced by glucocorticoids. In deficiency of glucocorticoids, circulating catecholamines are less.</li>\n<li>Epinephrine and norepinephrine are metabolised to biologically inactive products by oxidation (MAO) and methylation (COMT).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Monoamine oxidase (MAO) (Option A): </strong>Involved in oxidative deamination and breakdown of catecholamines; not involved in epinephrine synthesis.</p>\n<p><strong>Catechol-O-methyltransferase (COMT) (Option B): </strong>Catalyzes methylation of catecholamines at different positions for degradation.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>PNMT</strong> is the enzyme that catalyzes the final step in catecholamine biosynthesis, <strong>the conversion of norepinephrine to epinephrine</strong>, and is regulated by <strong>glucocorticoids</strong> from the adrenal cortex.</p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycogenolysis in skeletal muscle</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased insulin secretion</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Vasoconstriction in most vascular beds</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased metabolic rate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is most accurately mediated via &beta;-adrenergic receptors?</span></p>",
      "unique_key": "DT1320877",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320877,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Glycogenolysis induced by catecholamines is mediated via &beta;-adrenergic receptors that activate cAMP and phosphorylase.</p>\n<ul>\n<li><strong>Catecholamines (epinephrine and norepinephrine)</strong> cause glycogenolysis in the liver and skeletal muscle through <strong>&beta;-receptor activation</strong>, which increases cAMP and activates phosphorylase.</li>\n<li>They also act via <strong>&alpha;-receptors</strong>, which increase intracellular Ca<sup>2+</sup>, aiding further glycogenolysis.</li>\n<li><strong>&beta;-adrenergic activation</strong> also increases insulin and glucagon secretion, while <strong>&alpha;-adrenergic activation</strong> inhibits their secretion. <strong>(Option B ruled out)</strong></li>\n<li>These hormones raise metabolic rate and alertness. <strong>(Option D ruled out)</strong></li>\n<li><strong>Vasoconstriction</strong> in most tissues is primarily mediated by <strong>&alpha;<sub>1</sub>-receptors</strong>, not &beta;-receptors. <strong>(Option C ruled out)</strong></li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>&beta;-adrenergic activation by catecholamines leads to glycogenolysis, increased cAMP, and metabolic stimulation. &alpha;-adrenergic mechanisms exert opposite effects on insulin/glucagon.</p>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}